Learn about Bone Density Screening (DEXA Scan, Bone Mineral Density Test) for osteoporosis screening and diagnosis. This resource provides information for healthcare professionals on clinical documentation and medical coding related to low bone density, osteoporosis, and fracture risk assessment. Find details on ICD-10 codes, CPT codes, and best practices for bone density testing and reporting in medical records.
Also known as
Encounter for bone density screening
Encounter for screening for decreased bone density.
Other osteoporosis without current pathological fracture
Generalized osteoporosis without current fracture, screened.
Osteoporosis, unspecified, without current pathological fracture
Unspecified osteoporosis without fracture, may include screening context.
Encounter for other specified special screening examinations
Includes encounters for bone density screening as part of broader screening.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the bone density screening for osteoporosis risk assessment?
When to use each related code
| Description |
|---|
| Checks bone strength, screens for osteoporosis. |
| Diagnosed decrease in bone mass, increased fracture risk. |
| Low bone mass, higher than normal fracture risk. |
Insufficient documentation to support medical necessity for DEXA scan, leading to denials and compliance issues.
Incorrect Z-code usage for screening vs. diagnostic DEXA, impacting reimbursement and data accuracy.
Missing or inaccurate diagnosis code for a fracture or related condition, affecting risk adjustment and quality reporting.
Q: What are the most effective bone density screening guidelines for postmenopausal women with no prior fractures, considering risk factors like family history and glucocorticoid use?
A: Current guidelines, including those from the National Osteoporosis Foundation (NOF), recommend bone mineral density testing (BMD) with dual-energy X-ray absorptiometry (DEXA scan) for all women age 65 and older regardless of risk factors. For postmenopausal women younger than 65, the decision to pursue osteoporosis screening should be based on individual risk factors such as family history of hip fracture, current glucocorticoid use, low body weight, smoking history, and excessive alcohol consumption. Clinicians should use a validated FRAX (Fracture Risk Assessment Tool) score to estimate 10-year fracture probability and consider initiating BMD testing if the risk is comparable to or exceeds that of a 65-year-old white woman without major risk factors. Explore how integrating FRAX scores into your practice can improve osteoporosis screening decisions. Consider implementing a standardized risk assessment protocol for all postmenopausal women to ensure appropriate and timely bone density screening.
Q: How do I interpret T-scores and Z-scores from a DEXA scan to accurately diagnose osteoporosis and osteopenia, and what follow-up steps are warranted based on the results?
A: DEXA scan T-scores compare a patient's bone mineral density (BMD) to the average BMD of a young healthy adult of the same sex. A T-score of -1.0 or above is considered normal. Osteopenia is diagnosed with a T-score between -1.0 and -2.5, while osteoporosis is diagnosed with a T-score of -2.5 or below. Z-scores, on the other hand, compare the patient's BMD to the average BMD of someone their own age, sex, and ethnicity. A significantly low Z-score (typically below -2.0) may suggest a secondary cause of bone loss beyond age-related decline, warranting further investigation. Following diagnosis, appropriate management strategies should be implemented. For patients with osteopenia, lifestyle modifications like increasing calcium and vitamin D intake, weight-bearing exercise, and smoking cessation are recommended. Learn more about the latest recommendations for osteoporosis management based on T-scores and fracture risk. Consider implementing a patient education program on lifestyle modifications for bone health.
Patient presented for bone density screening due to concerns regarding osteoporosis risk. Relevant risk factors discussed included age, family history of osteoporosis, and current medication regimen. A dual-energy x-ray absorptiometry (DEXA) scan, also known as a bone mineral density test, was ordered and performed today to assess bone health and fracture risk. The patient's T-score and Z-score will be documented upon result availability. Preliminary findings, clinical indications, and differential diagnoses for low bone density, including osteopenia and osteoporosis, will be reviewed with the patient upon receipt of the final DEXA scan report. A comprehensive treatment plan, including lifestyle modifications such as calcium and vitamin D supplementation, weight-bearing exercise, and fall prevention strategies, will be discussed if indicated. Pharmacological interventions, such as bisphosphonates or other osteoporosis medications, will be considered based on the final bone density results and FRAX score assessment. Follow-up appointment scheduled to review results and formulate a personalized osteoporosis management plan. ICD-10 code Z13.820, Encounter for screening for osteoporosis, was used for this preventive health service. CPT code 77080, Dual-energy x-ray absorptiometry (DXA), bone density study, axial skeleton (eg, hips, pelvis, spine), was billed for the DEXA scan procedure.